Zydus Lifesciences Q2 net profit falls 26.6% to Rs 925.5 crore

What happened: Zydus Lifesciences reported a 26.6% decline in net profit to ₹925.5 crore for the September quarter, while revenue from operations rose 29.2%. Key numbers: Net profit ₹925.5 crore, down 26.6%. Revenue ₹7,909.6 crore, up 29.2%. Total expenses ₹6,806.6 crore. Pharmaceuticals 83% of sales. India formulations ₹1,884.4 crore. North America formulations ₹3,314.5 crore. Why it matters: Total expenses rose significantly, which the company said impacted profitability despite strong revenue growth and global performance in North America formulations.

Zydus Lifesciences reported a 26.6% decline in net profit to ₹925.5 crore for the September quarter, while revenue from operations rose 29.2%.

Total expenses rose significantly, which the company said impacted profitability despite strong revenue growth and global performance in North America formulations.